According to a recent survey of independent pharmacists, 93.2% of respondents have already decided not to participate in the program or are considering doing so, according to a Jan. 27 NCPA news release shared with Becker’s.
The survey also found that 60.4% of independent pharmacists are considering not stocking one or more of the first 10 drugs listed in the program, while 32.8% have already decided against stocking them.
In addition, 96.5% of independent pharmacists reported that reimbursement rates from pharmacy benefit managers and Medicare Part D plans are jeopardizing the financial health of their businesses. Many respondents reported receiving payments below the National Average Drug Acquisition Cost for a significant portion of Medicare Part D prescriptions, exacerbating the financial strain.
In an email shared with Becker’s, CMS stated, “HHS has issued a pause on mass communications and public appearances that are not directly related to emergencies or critical to preserving health. This is a short pause to allow the new team to set up a process for review and prioritization. There are exceptions for announcements that HHS divisions believe are mission critical, but they will be made on a case by case basis.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
